SEC Form 4 · accession 0000899243-18-010751
Whitehawk Therapeutics, Inc. · WHWK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen J Hoffman
Officer — Chief Executive Officer · Director
Period of report
Apr 23, 2018
Accepted (ET)
Apr 25, 2018 · 8:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001422142
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.59 | Apr 23, 2018 | A | 300,000 | A | — | Apr 23, 2028 | Common Stock | 300,000 | 300,000 | D |
Explanation of responses
- F1Options exercisable as to 1/4th on the first anniversary of the grant date and an additional 1/48th monthly thereafter until the fourth anniversary of the grant date.